Ginkgo Bioworks (DNA) · page 173 of 175
The slide uses expert testimony to argue that the two companies are undifferentiated and that Ginkgo's projects are higher risk.
Activist deck · quote_slide · expose_contradiction · dense density
Slide locked Sign in to view
Slide schematic 5/5
paragraph 1/1 quote 3/3 source-note 1/1
Components 5
paragraph testimonial testimonial testimonial source-note
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1